Adverse Outcomes in Alaska Natives Who Recovered From or Have Chronic Hepatitis C Infection

Gastroenterology

Volumn 138, Issue 3, 2010, Pages

  McMahon, Brian J ^a,b   Bruden, Dana ^b   Bruce, Michael G ^b   Livingston, Stephen ^a   Christensen, Carol ^a   Homan, Chriss ^a   Hennessy, Thomas W ^b   Williams, James ^a   Sullivan, Daniel ^c   Rosen, Hugo R ^d   Gretch, David ^c  

^a ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Hepatitis C in Alaska Natives; Hepatitis C Liver Related Decompensation and Death; Hepatitis C Population Outcome Study; Hepatitis C Virus

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ADVERSE OUTCOME; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CONVALESCENCE; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; INFECTION RISK; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE; UNITED STATES;

EID: 77649134018     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.10.056     Document Type: Article

References (27)

1. Afdhal N.H. The natural history of hepatitis C. Semin Liver Dis 24 (2004) 3-8
2. Strader D.B., Wright T., Thomas D.L., and Seeff L.B.A.A.f.t.S.o.L.Diseases. Diagnosis, management, and treatment of hepatitis C. Hepatology 39 (2004) 1147-1171
3. Goodgame B., Shaheen N.J., Galanko J., and El-Serag H.B. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias?. Am J Gastroenterol 98 11 (2003) 2535-2542
4. Poynard T., Bedossa P., and Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349 (1997) 825-832
5. Freeman A.J., Dore G.J., Law M.G., et al. Estimating progression to cirrhosis in chronic hepatitis C virus infection. Hepatology 34 (2001) 809-816
6. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 340 (1999) 1228-1233
7. Seeff L.B., Hollinger F.B., Alter H.J., et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 33 (2001) 455-463
8. Wiese M., Ber F., Lafrenz M., Porst H., and Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 32 (2000) 91-96
9. Harris D.R., Gonin R., Alter H.J., et al. The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse. Annals of Internal Medicine 134 (2001) 120-124
10. Thomas D.L., Asternborski J., Rai R.M., et al. The natural history of hepatitis C virus infection-host, viral, and environmental factors. JAMA 284 (2000) 450-456
11. Fattovich G., Giustina G., Degos F., et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 112 (1997) 463-472
12. McMahon B.J., Hennessy T.W., Ghristensen C., et al. Epidemiology and risk factors for hepatitis C in Alaska natives. Hepatology 39 (2004) 325-332
13. Alter M.J., Kruszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 341 (1999) 556-562
14. Bruden D.L., McMahon B.J., Hennessy T.W., et al. Estimating the date of hepatitis C virus infection from patient interviews and antibody tests on stored sera. Am J Gastroenterol 99 (2004) 1517-1522
15. Alaska Department of Labor and Workforce Development. Population estimates. http://almis.labor.state.ak.us/?PAGEID=67&SUBID=171 Accessed January 15, 2006
16. US Burea of the Census. Census of population and housing (2000), US Burea of the Census, Washington, DC
17. Newman S.C. Biostatistical Methods in Epidemiology (2001), John Wiley and Sons, New York, NY
18. Amin J., Law M.G., Bartlett M., Kaldor J.M., and Dore G.J. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
19. Neal K.R., Ramsay S., Thomson G.J., Irving W.L., and Trent Hepatitis C. Study Group. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 56 (2007) 1098-1104
20. Posthouwer D., Makris M., Yee T.T., et al. Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study. Blood 109 (2007) 3667-3671
21. Vong S., and Bell B.P. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 39 (2004) 476-483
22. Bhattacharya R., and Shuhart M.C. Hepatitis C and alcohol: interactions, outcomes, and implications. J Clin Gastroenterol 36 (2003) 242-252
23. Monto A., Patel K., Bostrom A., et al. Risks of a range of alcohol intake on hepatitis C-related fibrosis. Hepatology 39 (2004) 826-834
24. Chen C.J., Yang H.I., and Su J. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
25. Mengshol J.A., Golden-Mason L., and Rosen H.R. Mechanisms of disease: HCV-induced liver injury. Nat Clin Pract Gastroenterol Hepatol 4 (2007) 622-634
26. Livingston S.E., Deubner H., McMahon B.J., et al. Steatosis and hepatitis C in an Alaska Native/American Indian population. Int J Circumpolar Health 65 (2006) 253-260
27. Serra M.A., Escudero A., Rodriguez F., del Olmo J.A., and Rodrigo J.M. Effect of hepatitis C virus infection and abstinence from alcohol on survival in patients with alcoholic cirrhosis. J Clin Gastroenterol 36 (2003) 170-174